Concepedia

Publication | Open Access

Epidermal growth factor receptor targeted doxorubicin and vitexin loaded niosomes for enhanced breast cancer therapy

DOIFull Paper Access

10

Citations

51

References

2023

Year

S. Malathi, Valappil Sisila, Vijayapoopathi Singaravel, Nandakumar Venkatesan, Iqbal Pakrudheen, Rajesh Kumar Dhanaraj, Niraikulam Ayyadurai, V. Bhuvarahamurthy, S. Narayana Kalkura
Materials Advances

Abstract

NIODVC (cetuximab-conjugated doxorubicin and vitexin loaded niosome) proves effective for targeted breast cancer therapy. Enhanced cytotoxicity, cellular uptake, and gene downregulation show promise.

References

YearCitations

Page 1